These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8637784

  • 1. Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract.
    Gerber MA.
    Pediatrics; 1996 Jun; 97(6 Pt 2):971-5. PubMed ID: 8637784
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic resistance in group A streptococci.
    Gerber MA.
    Pediatr Clin North Am; 1995 Jun; 42(3):539-51. PubMed ID: 7761140
    [Abstract] [Full Text] [Related]

  • 3. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
    Yazgi H, Ertek M, Aktaş AE.
    Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
    [Abstract] [Full Text] [Related]

  • 4. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J, Ewig S, Kresken M.
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [Abstract] [Full Text] [Related]

  • 5. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB, Fernandes LA, Fernandes CJ.
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [Abstract] [Full Text] [Related]

  • 6. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z, Baysallar M, Gür D, Doğanci L.
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE, Debbia EA, Nicoletti G, Pavesio D, Ripa S, Schito GC, Tempera G.
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [Abstract] [Full Text] [Related]

  • 12. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R.
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [Abstract] [Full Text] [Related]

  • 13. Use of antibiotics in dental practice.
    Montgomery EH, Kroeger DC.
    Dent Clin North Am; 1984 Jul; 28(3):433-53. PubMed ID: 6589179
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA.
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [Abstract] [Full Text] [Related]

  • 16. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis.
    Casey JR, Pichichero ME.
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):39S-45S. PubMed ID: 17292576
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.